Cardiorespiratory fitness linked with decreased metabolic syndrome risk among smokers
the ONA take:
According to a new study published in the American Journal of Preventive Medicine, researchers from The University of Texas Health Science Center at Houston School of Public Health in Houston, Texas, have found that cardiorespiratory fitness is associated with a decreased risk of metabolic syndrome among smokers.
For the study, researchers analyzed data from 1,249 adult smokers who participated in the Cooper Center Longitudinal Study between 1979 and 2011.
Results showed that smokers with the highest level of cardiopulmonary fitness had a 48% decreased risk of metabolic syndrome compared with those with lowest level of fitness. Those who did moderate fitness had a 27% lower risk versus those who had low fitness levels.
"Study findings indicate that there is an inverse relationship between cardiorespiratory fitness and cardiometabolic risk among adult smokers" said Darla Kendzor, Ph.D., assistant professor in the Department of Health Promotion and Behavioral Sciences at UTHealth School of Public Health Dallas Regional Campus.
Although the findings show that fitness is beneficial among smokers, the authors stress the importance of smoking cessation to decrease overall morbidity and mortality.
Cardiorespiratory fitness is associated with a decreased risk of metabolic syndrome among smokers.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|